LOS ANCIANOS CON NEOPLASIAS DE CABEZA Y CUELLO NO RECIBEN EL TRATAMIENTO ADECUADO





LOS ANCIANOS CON NEOPLASIAS DE CABEZA Y CUELLO NO RECIBEN EL TRATAMIENTO ADECUADO

(especial para SIIC © Derechos reservados)
Estos pacientes a menudo no reciben tratamiento adecuado por razones distintas de la comorbilidad. Dado que el impacto de la terapia sobre la calidad de vida es similar al de sujetos más jóvenes, debe considerarse el tratamiento estándar si no existen comorbilidades graves.
derks9.jpg Autor:
Wynia Derks
Columnista Experto de SIIC

Institución:
Onze Lieve Vrouwe Gasthuis


Artículos publicados por Wynia Derks
Recepción del artículo
31 de Julio, 2007
Aprobación
27 de Septiembre, 2007
Primera edición
6 de Abril, 2009
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
Los pacientes ancianos con neoplasias de cabeza y cuello a menudo no reciben el tratamiento adecuado. Muchos trabajos muestran que se puede realizar el tratamiento quirúrgico radical sin peligro en pacientes ancianos siempre que no existan otras enfermedades asociadas. La radioterapia es tolerada muy bien incluso por los muy ancianos. Los datos sobre quimiorradioterapia combinada en esta población son muy escasos. La comorbilidad grave influye en la tasa de complicaciones posoperatorias y puede limitar la tolerancia a la quimioterapia. Una evaluación minuciosa del estado de salud del paciente previa al tratamiento y la optimización de su estado clínico son fundamentales en los ancianos. Sin embargo, en un análisis multivariado se demostró que incluso después de corregir la comorbilidad y otros factores, se mantenía el efecto de la edad sobre la elección del tratamiento. Las opiniones personales de los cirujanos de cabeza y cuello, los pacientes y sus familiares acerca de la tolerancia al tratamiento y la calidad de vida posterior pueden influir en la elección de la terapia. No obstante, un estudio de calidad de vida mostró que el impacto del tratamiento sobre la calidad de vida no difería entre los pacientes más jóvenes y más ancianos con cáncer de cabeza y cuello. Las presunciones erróneas de que "los ancianos son menos capaces de afrontar un tratamiento mayor" no deben jugar un papel en la elección terapéutica. Siempre se debe considerar el tratamiento estándar si no existen contraindicaciones graves.

Palabras clave
ancianidad, neoplasias de cabeza y cuello, comorbilidad, complicaciones posoperatorias, calidad de vida


Artículo completo

(castellano)
Extensión:  +/-10.5 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Elderly patients with head and neck cancer often receive substandard treatment. Numerous publications have shown that radical surgical treatment can be performed safely in elderly patients provided there is no severe comorbidity. Radiotherapy is tolerated very well even in very old patients. Data about combined chemoradiotherapy in the elderly are scarce. Severe comorbidity influences the rate of postoperative complications and can limit tolerance of chemotherapy. A thorough pre-treatment evaluation of a patient's health status and optimization of the patient's medical condition is crucial in elderly patients. However, in a multivariate analysis it was shown that even after correction for comorbidity and other factors, the effect of age on treatment choice remained. Personal opinions of head and neck surgeons, patients, and their family about treatment tolerance and quality of life after treatment can influence choice of therapy. Yet, a quality of life study showed that the impact of treatment on quality of life did not differ between younger and older patients with head and neck cancer. Mistaken assumptions such as "the elderly are less able to cope with major treatment" should not play a role in treatment choice. Standard treatment should always be considered if no severe contraindications exist.

Key words
elderly, head and neck neoplasms, comorbidity, postoperative complications, quality of life


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Geriatría
Relacionadas: Cirugía, Medicina Interna, Oncología, Otorrinolaringología, Salud Pública



Comprar este artículo
Extensión: 10.5 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Wynia Derks, Department of Otorhinolaryngology, 1090 HM, P.O. Box 95500, Amsterdam, Países Bajos
Bibliografía del artículo
1. U.S.Census Bureau. US interim projections by age, sex, race, and hispanic origin. Internet Communication. www.census.gov/ipc/www/usinterimproj. 2004.
2. Arias E. United States life tables, 2003. Natl Vital Stat Rep 54:1-40, 2006.
3. Derks W, De Leeuw JR, Hordijk GJ, Winnubst JA. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol 262:21-6, 2005.
4. Sarini J, Fournier C, Lefebvre JL, Bonafos G, Van JT, Coche-Dequeant B. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 127:1089-92, 2001.
5. Barzan L, Veronesi A, Caruso G, Serraino D, Magri D, Zagonel V et al. Head and neck cancer and ageing: a retrospective study in 438 patients. J Laryngol Otol 104:634-40, 1990.
6. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope 117:835-40, 2007.
7. Bernardi D, Barzan L, Franchin G, Cinelli R, Balestreri L, Tirelli U et al. Treatment of head and neck cancer in elderly patients: state of the art and guidelines. Crit Rev Oncol Hematol 53:71-80, 2005.
8. Hirano M, Mori K. Management of cancer in the elderly: therapeutic dilemmas. Otolaryngol Head Neck Surg 118:110-4, 1998.
9. Kusaba R, Sakamoto K, Mori K, Umeno T, Nakashima T. Laboratory data and treatment outcomes of head and neck tumor patients in the elderly. Auris Nasus Larynx 28:161-8, 2001.
10. Visser O, Siesling S, Van Dijk JAAM. Incidence of cancer in the Netherlands 1999/2000. Utrecht: Vereniging van Integrale Kankercentra, 2003.
11. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 131:27-32, 2005.
12. Zabrodsky M, Calabrese L, Tosoni A, Ansarin M, Giugliano G, Bruschini R et al. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol 13:249-55, 2004.
13. Boruk M, Chernobilsky B, Rosenfeld RM, Har-El G. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg 131:605-9, 2005.
14. Derks W, De Leeuw JR, Hordijk GJ, Winnubst JA. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol Allied Sci 28:399-405, 2003.
15. Sesterhenn AM, Teymoortash A, Folz BJ, Werner JA. Head and neck cancer in the elderly: a cohort study in 40 patients. Acta Oncol 44:59-64, 2005.
16. Rapidis AD, Keramidas T, Panagiotopoulos H, Andressakis D, Angelopoulos AP. Tumours of the head and neck in the elderly: analysis of 190 patients. J Craniomaxillofac Surg 26:153-8, 1998.
17. Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H. Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 20:216-23, 1998.
18. Beausang ES, Ang EE, Lipa JE, Irish JC, Brown DH, Gullane PJ et al. Microvascular free tissue transfer in elderly patients: the Toronto experience. Head Neck 25:549-53, 2003.
19. Bridger AG, O'Brien CJ, Lee KK. Advanced patient age should not preclude the use of free-flap reconstruction for head and neck cancer. Am J Surg 168:425-8, 1994.
20. Suh JD, Sercarz JA, Abemayor E, Calcaterra TC, Rawnsley JD, Alam D et al. Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction. Arch.Otolaryngol.Head Neck Surg 130:962-6, 2004.
21. Borggreven PA, Kuik DJ, Quak JJ, De Bree R, Snow GB, Leemans CR. Comorbid condition as a prognostic factor for complications in major surgery of the oral cavity and oropharynx with microvascular soft tissue reconstruction. Head Neck 25:808-15, 2003.
22. Malata CM, Cooter RD, Batchelor AG, Simpson KH, Browning FS, Kay SP. Microvascular free-tissue transfers in elderly patients: the leeds experience. Plast Reconstr Surg 98:1234-41, 1996.
23. Shestak KC, Jones NF, Wu W, Johnson JT, Myers EN. Effect of advanced age and medical disease on the outcome of microvascular reconstruction for head and neck defects. Head Neck 14:14-8, 1992.
24. Genden EM, Rinaldo A, Shaha AR, Clayman GL, Werner JA, Suarez C et al. Treatment considerations for head and neck cancer in the elderly. J Laryngol Otol 119:169-74, 2005.
25. Haughey BH, Wilson E, Kluwe L, Piccirillo J, Fredrickson J, Sessions D et al. Free flap reconstruction of the head and neck: analysis of 241 cases. Otolaryngol Head Neck Surg 125:10-7, 2001.
26. Singh B, Cordeiro PG, Santamaria E, Shaha AR, Pfister DG, Shah JP. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 103:403-11, 1999.
27. Blackwell KE, Azizzadeh B, Ayala C, Rawnsley JD. Octogenarian free flap reconstruction: complications and cost of therapy. Otolaryngol Head Neck Surg 126:301-6, 2002.
28. Allal AS, Maire D, Becker M, Dulguerov P. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer 88:648-52, 2000.
29. Zachariah B, Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin North Am 14:131-67, 2000.
30. Olmi P, Ausili-Cefaro G, Loreggian L. Radiation therapy in the elderly with head and neck cancer. Rays 22:77-81, 1997.
31. Lusinchi A, Bourhis J, Wibault P, Le Ridant AM, Eschwege F. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Oncol Biol Phys 18:819-23, 1990.
32. Pignon T, Horiot JC, Van den BW, Van Glabbeke M, Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 32A:2075-81, 1996.
33. Zachariah B, Balducci L, Venkattaramanabalaji GV, Casey L, Greenberg HM, Del Regato JA. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 39:1125-9, 1997.
34. Airoldi M, Cortesina G, Giordano C, Pedani F, Gabriele AM, Marchionatti S et al. Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130:161-6, 2004.
35. Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol 22:262-8, 2004.
36. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-7, 2001.
37. Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Thurlimann B et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 18:1412-22, 2000.
38. Yuen AR, Zou G, Turrisi AT, Sause W, Komaki R, Wagner H et al. Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 89:1953-60, 2000.
39. Farwell DG, Reilly DF, Weymuller EA Jr, Greenberg DL, Staiger TO, Futran NA. Predictors of perioperative complications in head and neck patients. Arch Otolaryngol Head Neck Surg 128:505-11, 2002.
40. Serletti JM, Higgins JP, Moran S, Orlando GS. Factors affecting outcome in free-tissue transfer in the elderly. Plast Reconstr Surg 106:66-70, 2000.
41. Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer 88:653-63, 2000.
42. Derks W, De Leeuw RJ, Hordijk GJ. Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival. Curr Opin Otolaryngol Head Neck Surg 13:92-6, 2005.
43. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst 86:1766-70, 1994.
44. Bennahum DA, Forman WB, Vellas B, Albarede JL. Life expectancy, comorbidity, and quality of life. A framework of reference for medical decisions. Clin Geriatr Med 13:33-53, 1997.
45. Berkman B, Rohan B, Sampson S. Myths and biases related to cancer in the elderly. Cancer 74:2004-8, 1994.
46. Derks W, De Leeuw RJ, Hordijk GJ, Winnubst JA. Quality of life in elderly patients with head and neck cancer one year after diagnosis. Head Neck 26:1045-52, 2004.
47. Derks W, De Leeuw R, Winnubst J, Hordijk GJ. Elderly patients with head and neck cancer: physical, social and psychological aspects after 1 year. Acta Otolaryngol 124:509-14, 2004.
48. De Graeff A, De Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 22:398-407, 2000.
49. Hammerlid E, Mercke C, Sullivan M, Westin T. A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy. Oral Oncol 33:189-96, 1997.
50. Baider L, Andritsch E, Uziely B, Goldzweig G, Ever-Hadani P, Hofman G et al. Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings. Crit Rev Oncol Hematol 46:5-16, 2003.
51. Broeckel JA, Jacobsen PB, Balducci L, Horton J, Lyman GH. Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 62:141-50, 2000.
52. Parker PA, Baile WF, De Moor C, Cohen L. Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology 12:183-93, 2003.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618